Income Statement - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | |
|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total operating expenses | 177.53 | 94.31 | 74.59 | 36.91 | 8.70 |
| Operating income | -177.53 | -94.31 | -74.59 | -36.91 | -8.70 |
| Non-operating income (net) | 11.23 | 13.82 | 5.26 | 0.00 | -42.91 |
| Income before tax | -166.31 | -80.49 | -69.33 | -36.91 | -51.61 |
| Income tax expense | -80.49 | -36.91 | -11.59 | ||
| Net income | -166.31 | -80.49 | -69.33 | -36.91 | -51.61 |
Show Quarterly Income Statement
Income Statement - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total operating expenses | 46.11 | 38.82 | 38.32 | 33.62 | 66.77 | 23.71 | 24.23 | 25.70 | 20.67 | 23.12 | 16.72 | 22.58 | 12.17 | 10.44 | 11.77 | 7.35 | 7.35 |
| Operating income | -46.11 | -38.82 | -38.32 | -33.62 | -66.77 | -23.71 | -24.23 | -25.70 | -20.67 | -23.12 | -16.72 | -22.58 | -12.17 | -10.44 | -11.77 | -7.35 | -7.35 |
| Non-operating income (net) | 2.79 | 3.28 | 3.34 | 2.22 | 2.39 | 3.07 | 3.67 | 3.82 | 3.26 | 1.93 | 2.32 | 1.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income before tax | -43.32 | -35.54 | -34.98 | -31.40 | -64.39 | -20.63 | -20.56 | -21.87 | -17.42 | -21.19 | -14.40 | -21.57 | -12.17 | -10.44 | -11.77 | -7.35 | -7.35 |
| Income tax expense | -23.12 | -16.72 | -12.17 | -10.44 | -11.77 | ||||||||||||
| Net income | -43.32 | -35.54 | -34.98 | -31.40 | -64.39 | -20.63 | -20.56 | -21.87 | -17.42 | -21.19 | -14.40 | -21.57 | -12.17 | -10.44 | -11.77 | -7.35 | -7.35 |